Mount Sinai Innovation Partners

Mount Sinai Innovation Partners (MSIP) functions as the central entity responsible for driving the real-world application and commercialization of discoveries and inventions originating from the Mount Sinai Health System. It actively engages in developing strategic research partnerships with industry, leveraging Mount Sinai's extensive research output to foster innovation. The organization's core capability lies in its structured approach to identifying promising intellectual property and navigating the complex path from academic research to tangible healthcare solutions.

Established within the Mount Sinai Health System, MSIP was formed with the explicit insight that groundbreaking scientific research requires a dedicated bridge to commercial development for its full impact to be realized. While not founded by individual entrepreneurs in the traditional sense, its establishment reflects a commitment by Mount Sinai to accelerate the translation of scientific advancements. Erik Lium, PhD, serves as President, overseeing the strategic direction and operational execution of this critical translational mission.

MSIP primarily serves Mount Sinai researchers by providing commercialization expertise for their scientific breakthroughs, and industry partners seeking collaboration opportunities to develop novel healthcare products and services. Its overarching vision is to translate these discoveries and inventions into health care products and services that ultimately benefit patients and society at large. The organization continually seeks to expand its collaborative ecosystem to bring innovative solutions to market.